283 related articles for article (PubMed ID: 30032906)
41. Intratympanic and systemic steroids for sudden hearing loss.
Koltsidopoulos P; Bibas A; Sismanis A; Tzonou A; Seggas I
Otol Neurotol; 2013 Jun; 34(4):771-6. PubMed ID: 23652330
[TBL] [Abstract][Full Text] [Related]
42. Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial.
Yang W; Li X; Zhong J; Mei X; Liu H; Yang L; Lu L; Hu H
Trials; 2020 Feb; 21(1):135. PubMed ID: 32014060
[TBL] [Abstract][Full Text] [Related]
43. Intratympanic injection of dexamethasone as an alternative treatment of steroid-dependent sensorineural hearing loss associated with aortitis syndrome.
Murofushi T; Nakahara H; Sakata A; Matsuzaki M
Auris Nasus Larynx; 2007 Jun; 34(2):225-8. PubMed ID: 17049780
[TBL] [Abstract][Full Text] [Related]
44. [Intratympanic dexamethasone for sudden sensorineural hearing loss].
Lu Y; Ren J; Wu W; Yin T; Tang Y; Xie D
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jan; 20(1):11-2. PubMed ID: 16548148
[TBL] [Abstract][Full Text] [Related]
45. [Intratympanic injection therapy for therapy refractory acute hearing loss: A safe option for secondary treatment].
Mühlmeier G; Maier S; Maier M; Maier H
HNO; 2015 Oct; 63(10):698-700, 702-6. PubMed ID: 26395186
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.
Bae SC; Noh HI; Jun BC; Jeon EJ; Seo JH; Park SY; Kim JK; Lee DH; Oh JH; Park SN; Yeo SW
Acta Otolaryngol; 2013 May; 133(5):428-33. PubMed ID: 23356871
[TBL] [Abstract][Full Text] [Related]
47. [Time of salvage treatment on sudden sensorineural hearing loss].
Liu Y; Zhang C; Cao H; Jiang W; Yang H; Li Z; Chen Q; Chang E; Fan T; Hu R; Zhou E
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Apr; 29(8):719-22. PubMed ID: 26248445
[TBL] [Abstract][Full Text] [Related]
48. Sudden sensorineural hearing loss during pregnancy: clinical characteristics, management and outcome.
Xu M; Jiang Q; Tang H
Acta Otolaryngol; 2019 Jan; 139(1):38-41. PubMed ID: 30664387
[TBL] [Abstract][Full Text] [Related]
49. Comparative Evaluation of Injection Dexamethasone and Oral Glycerol Versus Injection Dexamethasone Alone in the Treatment of Sudden Onset Sensorineural Deafness.
Mehta N; Mehta S
Ear Nose Throat J; 2021 Jun; 100(3_suppl):317S-324S. PubMed ID: 32921155
[TBL] [Abstract][Full Text] [Related]
50. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
Chou YF; Chen PR; Kuo IJ; Yu SH; Wen YH; Wu HP
Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
[TBL] [Abstract][Full Text] [Related]
51. Noninvasive intratympanic dexamethasone treatment for sudden sensorineural hearing loss.
Zhang Q; Song H; Peng H; Yang X; Zhou J; Huang W
Acta Otolaryngol; 2012 Jun; 132(6):583-9. PubMed ID: 22339625
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial.
Ashtiani MK; Firouzi F; Bastaninejad S; Dabiri S; Nasirmohtaram S; Saeedi N; Ghazavi H; Sahebi L
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):89-97. PubMed ID: 29149379
[TBL] [Abstract][Full Text] [Related]
53. Potential Benefits of Combination Therapy as Primary Treatment for Sudden Sensorineural Hearing Loss.
Lee JB; Choi SJ
Otolaryngol Head Neck Surg; 2016 Feb; 154(2):328-34. PubMed ID: 26556463
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant Migraine Medications in the Treatment of Sudden Sensorineural Hearing Loss.
Abouzari M; Goshtasbi K; Chua JT; Tan D; Sarna B; Saber T; Lin HW; Djalilian HR
Laryngoscope; 2021 Jan; 131(1):E283-E288. PubMed ID: 32243585
[TBL] [Abstract][Full Text] [Related]
55. Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.
Li L; Ren J; Yin T; Liu W
Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):861-7. PubMed ID: 22669272
[TBL] [Abstract][Full Text] [Related]
56. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.
Gouveris H; Schuler-Schmidt W; Mewes T; Mann W
Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933
[TBL] [Abstract][Full Text] [Related]
57. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
Plaza G; Herráiz C
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
[TBL] [Abstract][Full Text] [Related]
58. [Comparative study of intratympanic Dexamethasone injection for sudden deafness at different time intervals].
Yang PL; Zhang ZP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):822-824. PubMed ID: 29774994
[No Abstract] [Full Text] [Related]
59. Steroid-based treatments for patients with total sudden sensorineural hearing loss.
Nakache G; Migirov L; Trommer S; Drendel M; Wolf M; Henkin Y
Acta Otolaryngol; 2015 Sep; 135(9):907-13. PubMed ID: 25857447
[TBL] [Abstract][Full Text] [Related]
60. Evaluation and comparison of the efficacy of long-acting betamethasone and dexamethasone as injections in the treatment of idiopathic sudden hearing loss.
Abdullah H; Erfanian R; Yazdani N; Hajbegloo S; Tajdini A
Am J Otolaryngol; 2021; 42(4):102955. PubMed ID: 33588138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
